The influence of developmental age on the early transcriptomic response of children with septic shock

James L Wynn1, Natalie Z Cvijanovich, Geoffrey L Allen

  • 1Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, United States of America.

Insights

Septic shock impacts children differently by age. Neonates show reduced immune gene expression, unlike older children, highlighting the need for age-specific sepsis treatments.

Area of Science:

  • Pediatric critical care medicine
  • Immunology
  • Genomics

Background:

  • Septic shock is a significant cause of mortality and morbidity in pediatric intensive care units (PICUs).
  • Host response variations contribute to diverse patient outcomes.
  • Genome-wide expression patterns offer molecular insights into sepsis pathogenesis.

Purpose of the Study:

  • To investigate age-specific differences in the host's genomic response to septic shock in children.
  • To compare gene expression patterns across distinct developmental age groups admitted to the PICU with septic shock.

Main Methods:

  • Whole-blood genome-wide expression patterns were analyzed within 24 hours of PICU admission for children with septic shock.
  • Transcriptomes were compared between septic shock groups: neonates (≤28 days), infants (1 month-1 year), toddlers (2-5 years), and school-age children (≥6 years).
  • Age-matched controls were used for comparison.

Main Results:

  • Neonates with septic shock exhibited profound differences compared to older children.
  • Neonates showed reduced expression of genes in key innate and adaptive immunity pathways.
  • Unlike other age groups with upregulated transcriptomes, neonates displayed a predominantly downregulated transcriptome relative to controls.
  • Neonates and school-age children had the most uniquely regulated genes.

Conclusions:

  • Significant age-dependent variations exist in the host response to pediatric septic shock.
  • Neonatal sepsis involves distinct immune gene expression profiles compared to older children.
  • Age-specific research is crucial for developing targeted therapies to improve sepsis outcomes in children.